| Literature DB >> 31483287 |
David P De Souza1, Adrian Achuthan2, Man Ks Lee3, Katrina J Binger4, Ming-Chin Lee2, Sophia Davidson5, Dedreia L Tull1, Malcolm J McConville1,4, Andrew D Cook2, Andrew J Murphy3, John A Hamilton2,6, Andrew J Fleetwood2.
Abstract
Macrophage activation in response to LPS is coupled to profound metabolic changes, typified by accumulation of the TCA cycle intermediates citrate, itaconate, and succinate. We have identified that endogenous type I IFN controls the cellular citrate/α-ketoglutarate ratio and inhibits expression and activity of isocitrate dehydrogenase (IDH); and, via 13C-labeling studies, demonstrated that autocrine type I IFN controls carbon flow through IDH in LPS-activated macrophages. We also found that type I IFN-driven IL-10 contributes to inhibition of IDH activity and itaconate synthesis in LPS-stimulated macrophages. Our findings have identified the autocrine type I IFN pathway as being responsible for the inhibition of IDH in LPS-stimulated macrophages.Entities:
Keywords: Cellular immune response; Inflammation; Macrophages; Metabolism; Mitochondria
Mesh:
Substances:
Year: 2019 PMID: 31483287 PMCID: PMC6763227 DOI: 10.1172/JCI127597
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808